LSL Pharma Group Inc.
LSL.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3,272.13% | -- | -45.55% | -- | -- |
| Total Receivables | 69.68% | 93.54% | 116.47% | -- | 164.53% |
| Inventory | 103.63% | 45.59% | 16.54% | -- | 42.41% |
| Prepaid Expenses | 127.98% | 71.02% | 149.16% | -- | 100.59% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 95.90% | 63.99% | 41.06% | -- | 67.99% |
|
|
|||||
| Total Current Assets | 95.90% | 63.99% | 41.06% | -- | 67.99% |
| Net Property, Plant & Equipment | 42.79% | 27.34% | 24.55% | -- | 8.59% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 36.40% | 4.90% | -0.22% | -- | 1.91% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 8,028.48% | 0.00% | -3.31% | -- | 2.03% |
| Total Assets | 58.94% | 28.17% | 20.94% | -- | 15.95% |
|
|
|||||
| Total Accounts Payable | -15.93% | -14.41% | -37.66% | -- | 11.09% |
| Total Accrued Expenses | -40.08% | -- | -- | -- | -31.38% |
| Short-term Debt | -37.63% | -60.64% | 55.86% | -- | 32.54% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -67.33% | -35.68% | 160.15% | -- | 218.62% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -41.23% | -40.47% | -13.91% | -- | 32.97% |
|
|
|||||
| Total Current Liabilities | -41.23% | -40.47% | -13.91% | -- | 32.97% |
| Long-Term Debt | 147.31% | 104.14% | -7.82% | -- | -38.15% |
| Short-term Debt | -37.63% | -60.64% | 55.86% | -- | 32.54% |
| Capital Leases | 66.63% | 4.26% | -8.64% | -- | -2.44% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 18.08% | -11.51% | -11.06% | -- | 3.53% |
|
|
|||||
| Common Stock & APIC | 36.51% | 43.45% | 33.94% | -- | 80.51% |
| Retained Earnings | 24.91% | -9.48% | -8.33% | -- | -91.42% |
| Treasury Stock & Other | -8.24% | -- | -- | -- | -- |
| Total Common Equity | 163.97% | 109.16% | 78.66% | 176.94% | 67.64% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 163.97% | 109.16% | 78.66% | 176.94% | 67.64% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 163.97% | 109.16% | 78.66% | 176.94% | 67.64% |
|
|
|||||